SCHEMBL20224892

SCHEMBL20224892

O=c1[nH]cnc2c1c(F)cn2[C@@H]1O[C@H](CO)C[C@H]1O

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
ALB P02768 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.39
STING1 Q86WV6 1/20 0.37
ADK P55263 3/20 0.35
SLC29A1 Q99808 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20938192 0.87 ALDH1A1 (0.43) LMNAALDH1A1ALBMAPK1ADK
SCHEMBL26213918 0.81 LMNA (0.37) LMNAALDH1A1ALBMAPK1SMN1; SMN2
SCHEMBL20224942 0.80 LMNA (0.60) LMNASMN1; SMN2ADK
SCHEMBL22990432 0.80 ADK (0.54) LMNAALDH1A1ADKSLC29A1
SCHEMBL22990413 0.80 ALDH1A1 (0.64) LMNAALDH1A1ALBMAPK1SMN1; SMN2
SCHEMBL24166706 0.80 ADK (0.54) LMNAALDH1A1ADKSLC29A1
SCHEMBL21137753 0.80 ADK (0.54) LMNAALDH1A1ADKSLC29A1
SCHEMBL23989399 0.80 ADK (0.54) LMNAALDH1A1ADKSLC29A1
SCHEMBL23211481 0.80 ADK (0.54) LMNAALDH1A1ADKSLC29A1
SCHEMBL18510882 0.80 ADK (0.54) LMNAALDH1A1ADKSLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4242212-A2 STING MODULATOR COMPOUNDS WITH SULFAMATE LINKAGES, AND METHODS OF MAKING AND USING Takeda Pharmaceutical Company Limited (JP) 2023-09-13 EP disclosed
WO-2019180683-A1 STING MODULATOR COMPOUNDS WITH SULFAMATE LINKAGES, AND METHODS OF MAKING AND USING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-09-26 WO disclosed
WO-2018100558-A2 CYCLIC DINUCLEOTIDE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-06-07 WO disclosed